Ampliphi Biosciences Corp (NYSEAMERICAN:APHB - Get Free Report) traded up 2% on Monday . The stock traded as high as $2.12 and last traded at $2.08. 5,987 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 842,200 shares. The stock had previously closed at $2.04.
Ampliphi Biosciences Trading Down 2.0 %
Ampliphi Biosciences Company Profile
(
Get Free Report)
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Recommended Stories
Before you consider Ampliphi Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.
While Ampliphi Biosciences currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
